Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Amortization - Intangibles (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Amortization - Intangibles for 10 consecutive years, with $31059.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortization - Intangibles rose 228.95% to $31059.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $168375.0, a 180.74% increase, with the full-year FY2024 number at $110452.0, up 16.78% from a year prior.
  • Amortization - Intangibles was $31059.0 for Q3 2025 at Creative Medical Technology Holdings, up from $30742.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $75997.0 in Q4 2024 to a low of -$24087.0 in Q3 2024.
  • A 5-year average of $25346.4 and a median of $23021.0 in 2021 define the central range for Amortization - Intangibles.
  • Peak YoY movement for Amortization - Intangibles: plummeted 204.63% in 2024, then skyrocketed 228.95% in 2025.
  • Creative Medical Technology Holdings' Amortization - Intangibles stood at $23021.0 in 2021, then changed by 0.0% to $23021.0 in 2022, then rose by 10.86% to $25521.0 in 2023, then skyrocketed by 197.78% to $75997.0 in 2024, then tumbled by 59.13% to $31059.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Amortization - Intangibles are $31059.0 (Q3 2025), $30742.0 (Q2 2025), and $30577.0 (Q1 2025).